Abstract
The central goal of our laboratory is to understand the regulation of lymphoid cells through molecular mechanisms of signal transduction and transcriptional control. A long-standing focus has been on changes that influence the effector function of mature lymphocytes. Work in the laboratory is oriented toward the identification of new regulatory mechanisms using cell lines and primary cells, and the validation of these in vitro findings in mouse models of immune responses and diseases. In this review, we summarize key insights into the regulation of T helper cell function during the phase of immunity where effector responses arise de novo. Particular interest has been centered on cytokine gene regulation as part of T cell differentiation into the Th1 and Th2 subsets. Information on IL-4 receptor signaling and the role of NF-κB transcription factors is reviewed. Our more recent work is designed to understand how regulation at the Th 1/2 effector stages is related to the control of memory T cell survival, immune recall responses, and the role of these responses in immune-mediated disease.
Similar content being viewed by others
References
Paul WE, Seder RA: Lymphocyte responses and cytokines. Cell 1994;76:241–251.
Abbas AK, Murphy KM, Sher A: Functional diversity of helper T lymphocytes. Nature 1996;386:787–793.
Dalton DK Pitts-Meek S, Keshav S, Figari IS, Bradley A, Stewart TA: Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 1993;259:1739–1742.
Bochmer BS, Undem BJ, Lichtenstein LM: Immunological aspects of allergic asthma. Annu Rev Immunol 1994;12:295–335.
Wills-Karp, M: Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol 1999;17:255–281.
Ying S, Durham SR, Corrigan CJ, Hamid Q, Kay AB: Phenotype of cells expressing mRNA for TH2-type (interkeukin 4 and interleukin 5) and TH1-type (interleukin 2 and inteferony) cytokines in bronchoalveolar lavage and bronchial biopsies from a topic asthmatic and normal control sunbjects. Am J Respir Ceil Mol Biol 1995;12:477–487.
Cua DJ, Coffman RL, Stohlman SA: Exposure to T helper 2 cytokines in vivo before encounterwith antigen selects for T helper subsets via alterations in antigenpresenting cell function. Immunol 1996;157:2830–2836.
Lenschow DJ, Herold KC, Rhee L, et al.: CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes. Immunity 1996;5:285–293.
Maldonado-Lopez R, De Smedt T, Michel P, et al.: CD8 α+ and CD8a− subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J Exp Med 1999;189:587–592.
Le Gros G, Ben-Sasson SZ, Seder R, Finkelman FD, Paul WE: Generation of interleukin (IL-) 4-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells. J Exp Med 1990; 172:921–929.
Seder RA, Gazzinelli R, Sher A, Paul WE: IL-12 acts directly on CD4+T cells to enhance priming for 1FN-γ production and diminishes IL-4 inhibition of such priming. Proc Natl Acad Sci USA 1993;90:10,188–10,192.
Robinson D, Shibuya K, Mui A, et al.: IGIF does not drive Th1 development but synergizes with IL-12 for Interferon-γ production and activates IRAK and NF-kB. Immunity 1997;7:571–581.
Shimoda K, van Deusen J, Sangster MY, et al.: Lack of IL-4-induced Th2 response and IgE class switching in mice with a disrupted Stat6 gene. Nature 1996; 380:630–633.
Zheng WP, Flavell RA: The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 1997;89:587–596.
Ouyang, W, Lohning M, Gao Z, Assenmacher M, Murphy KM: Stato-independent GATA-3 auto-activation directs IL-4-independent Th2 development and commutment. Immunity, 2000; 12:27–37.
Ranger AM, Hodge MR, Gravallese EM, et al.: Delayed lymphoid repopulation with defects in IL-4-driven responses produced by inactivation of NF-ATc. Immunity 1998;8:125–134.
Kim JI, Hol C, Grusby MJ, Glimcher LH: The transcription factor c-Maf controls the production of interleukin-4 but not other Th2 cytokines. Immunity 1999;10:745–751.
Das J, Chen C-H, Yang L, Cohn L, Ray P, Ray A: A critical role for NF-[kappa]B in Gata 3 expression and TH 2 differentiation in allergic airway inflammation. Nat Immunol 2001;2:45–50.
Agarwal S, Rao A: Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation. Immunity 1998;9:765–775.
Jankovic D, Kullberg MC, Noben-Trauth N, Caspar P, Paul WE, Sher A: Single cell analysis reveals that IL-4 receptor/Stat6 signalingisnot required for the in vivo or in vitro development of CD4+ lymphocytes with a Th2 cytokine profile. J Immunol 2000;164:3047–3055.
Noben-Trauth N, Shultz LD, Brombacher F, Urban JF, Gu H, Paul WE: An interleukin 4 (IL-4)-independent pathway for CD4+ T cell IL4 production is revealed in IL-4 receptor-deficient mice. Proc Natl Acad Sci USA 1997;94:10,838–10,843.
Finkelman FD, Morris SC, Orekhova T, et al.: State regulation of in vivo IL-4 responses. J Immunol 2000;164:2303–2310.
Kurata H, Lee HJ, O'Garra A, Arai N: Ectopic expression of activated State induces the expression of Th2-specific cytokines and transcription factors in developing Th1 cells. Immunity 1999;11:677–688.
Huang HJ, Hu-Li SZ, Ben-Sasson and Paul WE: IL-4 and IL-13 production in differentiated T helper type 2 cells is not IL-4 dependent. J Immunol 1997;159:3731–3738.
Magram J, Connaughton SE, Warrier RR, et al.: IL-12-deficient mice are defective in IFN-γ production and type 1 cytokine responses. Immunity 1996;4:141–181.
Thierfelder WE, van Deursen JM, Yamamoto K, et al.: Requirement for State in interleukin-12-mediated responses of natural killer and T cells. Nature 1996; 382:171–174.
Lohoff M, Ferrick D, Mittrucker H-W, et al.: Interferon regulatory factor-1 is required for a T helper 1 immuneresponse in vivo. Immunity 1997;6:681–689.
Taki S, Sato T, Ogasawara K, et al.: Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. Immunity 1997;6:673–679.
Goenka S, Youn J, Dzurek L, Schindler U, Yu-Lee L-Y, Boothby M: Paired State C-terminal transcription activation domains required both for inhibition of an interferon-responsive promoter and for trans-activation. J Immunol 1999;163:4663–4672.
Ohmori Y, Schrieber RD, Hamilton TA: Synergy between interferon-gamma and tumor necrosis factor-alpha in transcriptional activation is mediated by cooperation between signal transducerandactivator of transcription 1 and nuclear factor kappa B. J Biol Chem 1997; 272:14,899–14,907.
Galon J, Sudarshan C, Ito S, Finbloom D, O'Shea JJ: IL-12 induces IFN regulating factor-1 (IRF-1) gene expression in human NK and T cells. J. Immunol 1999;162:7256–7262.
Adachi O, Kawai T, Takeda K, et al.: Targeted disruption of the MyD88 gene results in loss of IL-1α and IL-18-mediated function. Immunity 1998;9:43–150.
Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D, Miyamoto S: Rel/NF-kB/IkB family: intimate tales of association and dissociation. Genes Devel 1995;9:2723–2735.
Ghosh S, May MJ, Kopp EB: NF-kB and Rel proteins: Evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998;16:225–260.
Boothby M, Mora AL, Scherer DC, Brockman JA, Ballard DW: Perturbation of the T lymphocyte lineagein transgenic mice expressing a constitutive repressor of nuclear factor (NF)-kappa B. J Exp Med 1997;185:1897–1907.
Mora AL, Chen D, Boothby M, Rubin D: Lineage-specific differences among CD8+T cells in their dependence on NF-kB/Rel signaling. Eur J Immunol 1999;29:2968–2980.
Aronica MA, Mora AL, Mitchell DB, et al.: Preferential role for NF-kB/Rel signaling in the type 1 but not type 2 T cell-dependent immune response in vivo. J Immunol 1999;163:5116–5124.
Sica A, Dorman L, Viggiano V, et al.: Interaction of NF-kB and NFAT with the interferon-γ promoter. J Biol Chem 1997;272:30,412–30,420.
Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH: A novel transcription factor, T-bet, directs Thl lineage commitment. Cell 2000;100:655–669.
Szabo SJ, Dighe AS, Gubler U, Murphy KM: Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J Exp Med 1997;185:817–824.
Stobie L, Gurunathan S, Prussin C, Sacks DL, Glaichenhaus N, Wu CY, et al.: The role of antigen and IL-12 in sustaining Thl memory cells in vivo: IL-12 is required to maintain memory/effector Thl cells sufficient to mediate protection to an infectious parasite challenge. Proc Natl Acad Sci USA 2000;97:8427–8432.
Nelms K, Keegan AD, Zamorano J, Ryan JJ, Paul WE: The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol 1999;17:701–738.
O'Shea JJ: Jaks, STATs,cytokine signal transduction, and immunoregulation: are we there yet? Immunity 1997;7:1–11.
Shen CH, Stavnezer J: Interaction of State and NF-kappaB: direct association and synergistic activation of interleukin-4-inceced transcription. Mol Cell Biol 1998;18:3395–3404.
Wang L, Myers Jr. MG, Sun X, Aaronson SA, White M, Pierce JH: IRS-1: Essential for insulin- and IL-4-stimulated mitogenesis in hematopoietic cells. Science 1993; 261:1591–1594.
Myers MG, Grammer TC, Wang L-M, et al.: PI 3-kinase and pp70 S6K signaling during insulin, IGF-1, and IL-4 stimulation. J Biol Chem 1994;269:28,783–28,789.
Keegan AD, Nelms K, White M, Wang LM, Pierce JH, Paul WE: An IL-4 receptorregion containing an insulin receptor motifis important for IL-4-mediated IRS-1 phosphorylation and cell growth. Cell 1994;76:811–820.
Wang D-Z, Ray P, and Boothby M: Rapamycin inhibits interleukin 4-inductible phosphorylation of HMG-I(Y). J Biol Chem 1995; 270:22,924–22,932.
Wang DZ, Zamorano J, Keegan A, Boothby M: HMG-I(Y) phosphorylation status as a nuclear target regulated through the 14R motif of the IL-4 receptor. J Biol Chem 1997;272:25,083–25,090.
Kim J, Reeves R, Rothman P, Boothby M: The non-histone chromosomal protein HMG-I(Y) contributes to repression of the immunoglobulin heavy chain germline epsilon promoter. Eur J Immunol 1995;25:788–798.
Thanos D, Maniatis T: The high mobility group protein HMG I(Y) is required for NF-kappa B-dependent virus induction of the human IFN-beta gene. Cell 1992;71:777–789
Aronica MA, Goenka S, Boothby M: IL-4-dependent induction of Bcl-2 and Bcl-X in T lymphocytes through a State- and PI 3-kinase-independent pathway. Cytokine 2000;6:578–587.
Lischke A, Moriggl R, Brandlein S, et al.: The interleukin-4 receptor activates STAT5 by a mechanism that relies upon common gammachain. J Biol Chem 1998;273:31,222–31,228.
Yamashita M, Katsumata M, Iwashima M, et al.: T cell receptorinduced calcineurin activation regulates T helpertype2 cell development by modifying the interleukin 4 receptor signaling complex. J Exp Med 2000;191:1869–1878.
Mora AL, Youn J, Keegan AD, Boothby M: Mechanisms of NF-kB/Rel participation in the lymphokine-dependent proliferation of T lymphoid cells. J Immunol 2001;166:2218–2227.
Moriggl R, Sexl V, Piekoriz R, Topham D, Ihle JN: State activation is uniquely associated with cytokine signaling in peripehral T cells. Immunity 1999;11:225–233.
Youn J, Chen J, Goenka S, et al.: In vivo function of an IL-2Rβ/IL-4R α cytokine receptor chimera potentiates allergicairway disease. J Exp Med 1998;188:1803–1816.
Chen Y, Roslonies E, Boothby M, Chen J: Redirection of T cell effector function in vivo and enhanced collagen-induced arthritis mediated by an IL-2Rβ/IL-4Rα chimeric cytokinereceptor transgene. J Immunol 2001; in press
Ryan JJ, Reynold LJ, Keegan A, et al.: Growth and gene expression are predominantly controlled by distinct regions of the human IL-4 receptor. Immunity 1996;4:123–132
Quelle FW, Shimoda K, Thierfelder W, et al.: Cloning of mouse and human State, proteins that are tyrosine phosphorylated in resporses to IL-4 and IL-3 but are not required for mitogenesis. Mol Cell Biol 1995;15:3336–3344.
Moriggl R, Erhardt I, Kammer W, et al. Activation of STAT6 is not dependent on phosphotyrosinemediated dockingto the interleukin-4 receptor and can be blocked by dominant-negative mutants of both receptor subunits. Eur J Biochem 1998;251:25–35.
Cookson WOCM, Moffat MF: Asthma: anepidemic intheabsence of infection? Science 1997;275:41–42.
Prescott SL, Macaubes C, Yabuhara A, et al.: Developing patterns of T cell memory to environmental allergens in the first two years of life. Intl Arch Allergy & Immunol 1997;113:75–79.
Weiss ST: Environmental risk factors in childhoodasthma. Clin Exp Allergy 1998;5:29–34.
Kline JN, Hunninghake GW: T-lymphocyte dysregulation in asthma. Proc Soc Exp Biol Med 1994;207:243–253.
Cohn L, Tepper JS, Bottomly K: IL-4-independent induction of airway hyperresponsiveness by Th2, but not Th1 cells. J Immunol 1998;161:3813–3816.
Ruetten H, Thiemermann C: Interleukin-13 is a more potent inhibitor of the expression of induciblenitric oxide synthase in smooth muscle cells than in macrophages: a comparison with interleukin-4 and interleukin-10. Shock 1997;8: 409–414.
Li L, Xia Y, Nguyen A, et al.: Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces cotaxin expression by airway epithelial cells. J Immunol 1999; 162:2477–2524.
Stellato C, Matsukura S, Fal A, et al.: Differential regulation of epithelial-derived C-C chemokine expression by IL-4 and the gluco-corticoid budesonide. J Immunol 1999;163:5624–5632.
Sekiya T, Miyamasu M, Imanishi M, et al.: Inducible expression of a Th2-type CC chemokine thymus-and activation-regulated chemokine by human bronchial epithelial cells. J Immunol 2000;165:2205–2213.
Homer RJ, Elias JA: Consequences of long-term inflammation: Airway remodeling. Clin Chest Med 2000;21:331–343.
Tang C, Inman MD, Rooijen N, Yang P, Shen H, Matsumoto K, et al.: Th Typel-stimulating activity of lung macrophages inhibits Th2-mediated allergic airway inflamamtion by an IFN-γ-dependent mechanism. J Immunol 2001;166:1471–1481.
Dutton RW, Bradley LM, Swain SL: T cell memory. Annu Rev Immunol 1998;16:201–223.
Swain SL: Generation and in vivo persistence of polarized Th1 and Th2 memory cells. Immunity 1994;1:543–552.
London CA, Perez VL, Abbas AK: Functional characteristics and survival requirements of memory CD4+T lymphocytes in vivo. J Immunol 1999;162:766–773.
Tanchot C, Rocha B: Peripheral selection of T cell repertoires: the role of continuous thymus output. J Exp Med 1997;186:1099–1106.
Berzins SP, Boyd RL, Miller JF: The role of the thymus and recent thymic migrants in the maintenance of the adult peripheral lymphocyte pool. J Exp Med 1998; 187:1839–1848.
Kedl RM, Rees WA, Hildeman DA, Schaefer B, Mitchell T, Kappler J, et al.: T cells compete for access to antigen-bearing antigenpresenting cells. J Exp Med 2000;192:1105–1114.
Lee WT, Cole-Calkins J, Street NE: Memory T cell development in the absence of specific antigen priming. J Immunol 1996;157:5300–5307.
Hurst SD, Sitterding SM, Ji S, Barrett TA: Functional differentiation of T cells in the intestine of T cell receptor transgenic mice. Proc Natl Acad Sci USA 1997;94:3920–3925.
Launois P, Maillard I, Pingel S, et al.: IL-4 rapidly produced by Vβ4/Vα8CD4+T cells instructs Th2 development and susceptibility to leishmania major in BALB/c mice. Immunity 1997;6:541–549.
Nishimura T, Santa K, Yahata T, et al.: Involvement of IL-4-producing Vβ8.2+/CD4+/CD262L−/CD45RB− T cells in non-MHC gene-controlled predisposition toward skewing into T helper type-2 immunity in BALB/c mice. J Immunol 1997; 158:5698–5706.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Boothby, M., Mora, A.L., Aronica, M.A. et al. IL-4 signaling, gene transcription regulation, and the control of effector T cells. Immunol Res 23, 179–191 (2001). https://doi.org/10.1385/IR:23:2-3:179
Issue Date:
DOI: https://doi.org/10.1385/IR:23:2-3:179